NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter
Go back to NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter| NEOGENOMICS (NASDAQ: NEO) | Delayed: 19.91 +0.02 (0.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.89 | 52 Week High | $9.54 | |||
| Open | $19.91 | 52 Week Low | $5.49 | |||
| Day High | $20.03 | P/E | 497.75 | |||
| Day Low | $19.40 | EPS | $0.04 | |||
| Volume | 4,398,172 | |||||

